Literature DB >> 2136219

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

K Blennow1, A Wallin, P Fredman, C G Gottfries, I Karlsson, L Svennerholm.   

Abstract

Serum and cerebrospinal fluid (CSF) of 45 patients with Alzheimer's disease (AD) and 24 healthy controls were examined in order to investigate the possibility of an intrathecal synthesis of immunoglobulins in AD. The group of AD patients showed higher IgG and IgM indices than the control group. Five (11%) AD patients had an intrathecal IgG synthesis and 7 (15%) an intrathecal IgM synthesis. In total, 12 (26%) AD patients had an intrathecal immunoglobulin synthesis, while there was none among the controls. This finding supports the hypothesis that immunological mechanisms may play a role in the etiology and/or pathogenesis of Alzheimer's disease, at least in a subgroup of patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136219     DOI: 10.1016/0924-977x(90)90017-5

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

Review 2.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors:  Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

3.  Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

Authors:  Henrik Zetterberg; Niklas Mattsson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-14

4.  Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease.

Authors:  Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Journal:  Int J Alzheimers Dis       Date:  2010-12-19

5.  Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation.

Authors:  Heela Sarlus; Caroline Olgart Höglund; Bianka Karshikoff; Xiuzhe Wang; Mats Lekander; Marianne Schultzberg; Mircea Oprica
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

6.  Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Alessandro Fiorentini; Francesco Ursini; Alessandro Martorana; Giacomo Koch; Lorena Belli; Sofia Toniolo; Barbara Di Pietro; Caterina Motta; Orazio Schillaci
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 7.  Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.

Authors:  Lenka Hromadkova; Saak Victor Ovsepian
Journal:  J Immunol Res       Date:  2019-08-06       Impact factor: 4.818

Review 8.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.